Remove 2012 Remove Documentation Remove Hospitals
article thumbnail

Hospital pharmacist-led re-evaluation of medication errors: a pilot study

Hospital Pharmacy Europe

Karl-Johan Lindner and Marie Halvarsson, from the pharmacy at Västerås Hospital in Sweden, describe a new approach to improve the categorisation of medication errors that uses the skills of hospital pharmacists to reclassify reported incidents based on a given medication process. One million injections or infusions and 1.7

article thumbnail

Increasing patient engagement with UK clinical trials

pharmaphorum

An international key opinion former, Richard is the founding co-editor of the Journal of Research Involvement and Engagement, chairs BBMRI-ERIC’s Stakeholder Forum, and chaired the NCRI Consumer Forum 2012-2019. In 2014 Keith was fortunate to become a full-time salaried patient research ambassador at Liverpool Heart and Chest Hospital Trust.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The 20 Key Moments in the 340B Program's 30-Year History

Omnicell

Interestingly, the 340B law was actually included in a veterans healthcare bill (the Veterans Health Care Act) that also established a separate drug pricing program for veterans hospitals. It also raised the DSH payment cap for some rural and small urban hospitals to 12%. 340B providers expressed significant concern.

article thumbnail

Understanding the Nurse Practitioner Scope of Practice

Board Vitals - Pharmacist

between 2012 and 2015. The benefits offered by advanced level practitioners to practice is well documented as well. The study also found, “Physician-owned practices earned about $100,749 more after operating expenses per physician and hospital-owned practices earned $131,770 more.” or lower.”

article thumbnail

Developing the EU’s first intestinal microbiota-based biologic

European Pharmaceutical Review

European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults. 2012; 18 (6): 21-27. She worked at Cruces University Hospital focusing on pediatric brain tumours. References van Prehn J, Reigadas E, Vogelzang EH, et al.

article thumbnail

Long Time Passing: Where Have All the De Novo Decision Summaries Gone?

The FDA Law Blog

In 2012, the FDCA was modified to allow the submission of a De Novo request without the need for a prior 510(k), and set a target review time by FDA of 120 days. In effect, these documents serve as road signs helping to direct new market entrants.

FDA 69
article thumbnail

How to take care of your BIPOC patients

The Checkup by Singlecare

continues to impact BIPOC individuals and contribute to documented racial and ethnic disparities in health care. Read on to discover key ways you can improve care for BIPOC patients, whether you work as a pharmacist in a retail, hospital, or other setting. A long history of medical racism in the U.S.